| Mitochondrial control of inflammation S Marchi, E Guilbaud, SWG Tait, T Yamazaki, L Galluzzi Nature Reviews Immunology 23 (3), 159-173, 2023 | 510 | 2023 |
| Apoptotic cell death in disease—Current understanding of the NCCD 2023 I Vitale, F Pietrocola, E Guilbaud, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation 30 (5), 1097-1154, 2023 | 197 | 2023 |
| Targeting immunogenic cell stress and death for cancer therapy L Galluzzi, E Guilbaud, D Schmidt, G Kroemer, FM Marincola Nature Reviews Drug Discovery, 1-16, 2024 | 56 | 2024 |
| T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice V Bazioti, AM La Rose, S Maassen, F Bianchi, R de Boer, B Halmos, ... Nature communications 13 (1), 3799, 2022 | 38 | 2022 |
| Type I interferon and cancer P Holicek, E Guilbaud, V Klapp, I Truxova, R Spisek, L Galluzzi, ... Immunological Reviews 321 (1), 115-127, 2024 | 37 | 2024 |
| ABCA1 exerts tumor-suppressor function in myeloproliferative neoplasms M Viaud, O Abdel-Wahab, J Gall, S Ivanov, R Guinamard, S Sore, J Merlin, ... Cell reports 30 (10), 3397-3410. e5, 2020 | 22 | 2020 |
| Macrophage origin, metabolic reprogramming and IL-1β signaling: Promises and pitfalls in lung cancer E Guilbaud, EL Gautier, L Yvan-Charvet Cancers 11 (3), 298, 2019 | 22 | 2019 |
| Calreticulin exposure orchestrates innate immunosurveillance E Guilbaud, G Kroemer, L Galluzzi Cancer cell 41 (6), 1014-1016, 2023 | 15 | 2023 |
| The prohibitin-binding compound fluorizoline inhibits mitophagy in cancer cells S Núñez-Vázquez, J Saura-Esteller, I Sánchez-Vera, E Guilbaud, ... Oncogenesis 10 (9), 64, 2021 | 14 | 2021 |
| Cholesterol efflux pathways hinder KRAS-driven lung tumor progenitor cell expansion E Guilbaud, T Barouillet, M Ilie, C Borowczyk, S Ivanov, V Sarrazy, ... Cell stem cell 30 (6), 800-817. e9, 2023 | 12 | 2023 |
| Adaptation to MOMP drives cancer persistence E Guilbaud, L Galluzzi Cell Research 33 (2), 93-94, 2023 | 5 | 2023 |
| Inflammation and mitophagy are mitochondrial checkpoints to aging E Guilbaud, KA Sarosiek, L Galluzzi nature communications 15 (1), 3375, 2024 | 2 | 2024 |
| Cytofluorometric assessment of acute cell death responses driven by radiation therapy B Álvarez-Abril, N Bloy, C Galassi, A Sato, C Jiménez-Cortegana, V Klapp, ... Methods in Cell Biology 172, 17-36, 2022 | 2 | 2022 |
| 1106 Molecular mechanisms of immunogenic cell death driven by PT-112 E Guilbaud, T Yamazaki, M Congenie, C Yim, T Ames, L Galluzzi Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | 1 | 2023 |
| T cell-independent abscopal responses to radiotherapy E Guilbaud, T Yamazaki, L Galluzzi Trends in Cancer 9 (2), 93-95, 2023 | 1 | 2023 |
| Targeting mitophagy to maximize the immunostimulatory effects of radiation therapy in ER+ breast cancer E Guilbaud, A Sato, T Yamazaki, L Galluzzi Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1870 (8), 167381, 2024 | | 2024 |
| 777 Mitochondrial involvement in the cytotoxicity and immunogenicity of radiation therapy MB Visiedo, RS Agesta, E Guilbaud, A Sato, L Galluzzi Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| A mitochondrial checkpoint to NF-κB signaling E Guilbaud, L Galluzzi Cell Death & Disease 15 (7), 477, 2024 | | 2024 |
| PARP7 and nucleic acid-driven oncosuppression F Naulin, E Guilbaud, L Galluzzi Cellular & Molecular Immunology, 1-3, 2024 | | 2024 |
| Quantitative assessment of mitophagy in irradiated cancer cells E Guilbaud, S Spada, N Bloy, C Galassi, A Sato, C Jiménez-Cortegana, ... Methods in Cell Biology 174, 93-111, 2023 | | 2023 |
